z-logo
open-access-imgOpen Access
[Corrigendum] miR‑29a inhibits human retinoblastoma progression by targeting STAT3
Author(s) -
Shu Liu,
Xiaomeng Zhang,
Chunmei Hu,
Yingxue Wang,
Chunling Xu
Publication year - 2021
Publication title -
oncology reports
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.094
H-Index - 96
eISSN - 1791-2431
pISSN - 1021-335X
DOI - 10.3892/or.2021.8126
Subject(s) - regret , audience measurement , retinoblastoma , publication , oncogene , library science , psychology , cancer research , cancer , biology , cell cycle , medicine , computer science , political science , genetics , law , gene , machine learning
Following the publication of this article, an interested reader drew to the authors' attention that some western blotting data bands had apparently been duplicated in Fig. 4D. The authors have re‑examined their original data, and realized that this figure was assembled incorrectly. The corrected version of Fig. 4 is shown below. The authors sincerely apologize for the errors that were introduced during the preparation of this figure, and thank the Editor for allowing them the opportunity to publish a Corrigendum. Furthermore, they regret any inconvenience caused to the readership. [the original article was published in Oncology Reports 39: 739-746, 2018; DOI: 10.3892/or.2017.6144].

The content you want is available to Zendy users.

Already have an account? Click here to sign in.
Having issues? You can contact us here
Accelerating Research

Address

John Eccles House
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom